Related Experiment Video
Updated: Jun 17, 2026

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
[Background of the new definitions for pediatric multiple sclerosis]
1Regional Co-operation Office and Division of Pediatric Neurology, Shizuoka Children's Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 19, 2010
Summary
Pediatric multiple sclerosis (MS) presents differently than adult MS, often with polysymptomatic and encephalopathic features. New definitions aid in distinguishing MS from transient demyelinating syndromes in children.
Area of Science:
- Neurology
- Pediatrics
- Immunology
Context:
- Pediatric multiple sclerosis (MS) exhibits distinct clinical and radiological characteristics compared to adult-onset MS.
- Early-onset MS (under ten years) frequently presents with polysymptomatic and encephalopathic features.
- A significant portion of pediatric MS cases do not meet the established McDonald criteria on MRI.
Purpose:
- To differentiate between transient demyelinating syndromes and lifelong pediatric multiple sclerosis.
- To propose new definitions for pediatric MS and related disorders.
- To initiate surveillance of pediatric MS in Japan using updated diagnostic criteria.
Summary:
- Pediatric MS, particularly in younger children, shows unique features not seen in adults, including polysymptomatic and encephalopathic presentations.
- Diagnostic challenges exist, as MRI findings in pediatric MS often do not align with current McDonald criteria.
- Prognostic variability in pediatric MS necessitates refined classification, distinguishing it from conditions like biphasic inflammatory demyelination.
Impact:
- The implementation of new definitions facilitates more accurate diagnosis and classification of pediatric demyelinating diseases.
- Improved diagnostic criteria will enhance the surveillance and understanding of pediatric MS epidemiology in Japan.
- This work aims to clarify the long-term outlook for children diagnosed with demyelinating conditions, enabling better patient management.
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

